# The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI

> **NCT04316676** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 20 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DIAGNOSTIC_TEST:** PET-MPI Protocol
- **DIAGNOSTIC_TEST:** CT-MPI
- **DIAGNOSTIC_TEST:** Coronary CT angiography (CCTA) for CT-FFR calculation
- **DRUG:** Regadenoson

## Key facts

- **NCT ID:** NCT04316676
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-16
- **Primary completion:** 2024-09-24
- **Final completion:** 2024-09-24
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04316676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04316676, "The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04316676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*